CYH Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy

03
Cena $2.72
Kapitalizacja Rynkowa (MRQ) $384M
P/E (TTM) 1.5
EPS (TTM) $1.86
Przychody (TTM) $11.98B
ROE (TTM) -16.7%
D/E Dług/Kapitał (MRQ) -6.9
Zakres 52 tyg. $2–$4

CYH Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok

04
zakres
kreski

Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.

Podziały akcji 1
Data ex-dywidendy Podział Typ
22 kwietnia 2016 121-for-100 Naprzód

O Community Health Systems, Inc. Common Stock Przegląd firmy z Wikipedii

05 · wikidata

Community Health Systems, Inc. (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

In August 2015, the company announced plans to spin off 38 hospitals and its management and consulting subsidiary, Quorum Health Resources, into a new publicly traded company called Quorum Health Corporation. The company completed the spinoff of Quorum Health Corporation on April 29, 2016. Quorum owns or leases hospitals across 16 states, primarily in cities or counties with populations of 50,000 or less. In April 2020 Quorum declared bankruptcy and is no longer trading on the NYSE.

On October 3, 2016, CHS was removed from the S&P Midcap 400 and added to the S&P Smallcap 600. Under CEO Wayne T. Smith, the company's stock has lost over 76% of its value since the year 2000.

Chinese billionaire Tianqiao Chen had a 22.2 percent stake in Community Health Systems in 2017.

History

Founding and early years (1985–2014)

E. Thomas Chaney, former executive of Hospital Affiliates, Inc. and David Steffy and Richard Ragsdale, former executives at Hospital Corporation of America spinoff Republic Health Corporation, formed Community Health Systems in 1985.

The company made its initial public offering in 1991. In 1996, the company was purchased by private equity firm Forstmann Little & Company. Community Health Systems went public again in 2000. In August 2003, the company acquired Southside Regional Medical Center. On October 10, 2015, the 372-bed Grandview Medical Center began operating in Birmingham, Alabama, replacing Trinity Medical Center.

In 2000, Community Health Systems paid $31 million to the United States Department of Justice to settle a review of its billing practices.

In 2007, Community Health Systems purchased Plano, Texas-based Triad Hospitals for $6.8 billion, adding nearly 50 hospitals, hospital management and consulting business Quorum Health Resources, and nearly doubling the size of the company. Among the facilities included in the deal was McKenzie-Willamette Hospital in Springfield, Oregon; Trinity Medical Center in Birmingham, Alabama; and the seven hospitals of Lutheran Health Network in the Ft. Wayne, Indiana region.

In 2010, McKenzie-Willamette's healthcare workers' union, SEIU, Local 49, claimed that workload increases, slashed benefits, and staff reductions had lowered the quality of both patient care and quality of life for employees. The union, in its "Profits Before Community" campaign against the hospital, continues to highlight that profits have tripled while charitable care and employee benefits have steadily decreased since the hospital moved from a non-profit to a for-profit enterprise under CHS.

In 2011, it was accused by Tenet Healthcare of overbilling Medicare in its aggressive admissions policy compared to its peers. It was subpoenaed by Medicare on its aggressive billing to the Medicare systems.

In 2013, Community Health Systems entered into an agreement with Health Management Associates to purchase HMA for about $3.6 billion in cash and stock. The merger was completed in January 2014 and made Community Health Systems the largest for-profit hospital operator at the time, with 206 hospitals in 29 states. The acquisition of HMA brought with it liability for lawsuits and criminal charges of fraudulent claims against Medicare and other federal programs. CHS settled these claims for $262 million in October, 2018.

On August 4, 2014, Community Health Systems paid $95.14 million to the United States Department of Justice to resolve multiple lawsuits "alleging that the company knowingly billed government health care programs for inpatient services that should have been billed as outpatient or observation services". As part of the agreement, Community Health Systems was required to enter into a corporate integrity agreement that required the company to participate in compliance efforts.

It was reported on August 18, 2014, that hackers broke into Community Health System's records system and stole data on 4.5 million patients. These data included names, Social Security numbers, physical addresses, birthdays and telephone numbers. CHS provided all patients whose records were impacted with free identity theft protection.

Recent developments (2015–present)

On February 2, 2015, Community Health Systems was required to pay $75 million to settle allegations "that they made illegal donations to county governments to reap more federal dollars under a now-discontinued matching program". The allegations were brought about by a former CHS employee in a complaint under the False Claims Act.

In October 2015, Community Health Systems paid $13 million to the United States Department of Justice to resolve allegations related to the False Claims Act.

After CHS agreed in 2015 to sell Memorial Hospital of Salem County in New Jersey to Prime Healthcare Foundation, a nonprofit affiliated with Prime Healthcare Services; the sale was approved by New Jersey in early February 2017.

On December 6, 2016, a former CFO of a CHS hospital was awarded $1.9 million in a whistleblower lawsuit he filed after he was terminated for refusing to submit false financial documents.

In January 2017, a settlement between investors and CHS executives for $60 million was reached. The settlement resolved allegations of "breach of fiduciary duty" by CHS executives.

In March 2017, Quorum's board retained outside counsel in relation to whether Community Health Systems had committed fraud with regards to financial projections for Quorum, and whether any of its current management may have been involved in any possible fraud. In June 2017 Quorum said although the investigation did not produce "conclusive evidence" of fraud the projections appeared to be incompetent at best.

In April–July 2017, Community Health Systems rejected overtures from key Lutheran Health Network doctors to facilitate sale of its profitable network in CHS to a third party, after assertions of continual lack of re-investment into the network's facilities and staff by CHS management. After those discussions/accusations became public, several key leaders of the affiliated hospitals, Lutheran and Dupont, and the network were fired or resigned. Key prominent local community leaders Chuck Surack and Tom Kelley resigned from the Lutheran Health Network's and hospitals' advisory boards.

On March 13, 2018, it was reported that the company had hired financial advisory firm Lazard to help address long-term debt.

On August 1, 2018, CHS completed the sale of 425-bed Munroe Regional Medical Center in Ocala, Fla., to Altamonte Springs, Fla.-based Adventist Health System.

On May 22, 2019, AdventHealth announced they had signed definitive agreements to purchase 193-bed Heart of Florida Regional Medical Center in Davenport, Florida, and 160-bed Lake Wales Medical Center in Lake Wales, Florida, from affiliates of CHS.

In December 2019, CHS announced that subsidiaries of the company have completed the sale of three Virginia hospitals – Southside Regional Medical Center in Petersburg, Southampton Memorial Hospital in Franklin, and Southern Virginia Regional Medical Center in Emporia, effective on January 1, 2020.

On April 27, 2020, CHS announced that an affiliate of the company has signed a definitive agreement to sell its majority ownership interest in 84‑bed St. Cloud Regional Medical Center and its associated healthcare operations in St. Cloud, Florida, to a subsidiary of Orlando Health. Orlando Health currently holds minority ownership interest in St. Cloud and will purchase the remaining interest through this transaction.

On September 30, 2020, CHS announced that an affiliate of the company has completed the sale of 480-bed Bayfront Health St. Petersburg and its associated assets to a subsidiary of Orlando Health.

In its annual Form 10-K filed in 2019, it identified Florida, Texas and Indiana as areas of geographic concentration.

In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

From March 2020 to May 2021, during the COVID-19 pandemic, CHS filed more than 19,000 lawsuits against individuals for not being able to pay off their medical debt (some from hospitals it no longer owned) even as the company collected over $700 million in Covid relief funds from the federal government. Many of these lawsuits were against people who could not pay the legal fees to challenge CHS in court. (Due to the fact that these are civil suits and not criminal suits, the defendants do not receive a state-appointed lawyer.) In 2020, CHS posted its most profitable year in at least a decade.

Predatory liens practices

Lawsuits have been filed against CHS hospitals for alleged predatory liens practices where hospitals file for liens rather than bill individuals' health insurers, resulting in massive fees for patients.

Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗

Wikidata ↗

sektorHealth Care branżaHealth Care pracownicy44 000 krajUS

Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS

06
Przychody$12.48B
2016-12-31 → 2025-12-31
EPS$3.77
2016-12-31 → 2025-12-31
Wolny przepływ pieniężny$208M
2016-12-31 → 2025-12-31
Marża netto2.1%
2018-12-31 → 2025-12-31
Wycena i wskaźniki 07–12

Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?

Wskaźnik Trend 5-letni CYH średnia z 5 lat Mediana porównawcza Werdykt
P/E (TTM) 1.5średnia z 5 lat ≈3.4 ≈3.4 15.5 Niedowartościowany
P/S (TTM) 0.0średnia z 5 lat ≈0.1 ≈0.1 1.2 Niedowartościowany
P/B (MRQ) -0.3średnia z 5 lat ≈-0.5 ≈-0.5 · ·
EV / EBITDA 7.1średnia z 5 lat ≈13.1 ≈13.1 10.6 Niedowartościowany
Cena / FCF (TTM) -2.1średnia z 5 lat ≈-0.8 ≈-0.8 · ·
Cena / Przepływy pieniężne (TTM) 3.0średnia z 5 lat ≈-1.6 ≈-1.6 6.5 Niedowartościowany
EV / Revenue (EV / Przychody) 0.8średnia z 5 lat ≈1.0 ≈1.0 · ·
EV / FCF 50.5średnia z 5 lat ≈-4.9 ≈-4.9 · ·

Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.

wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany

Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR

13
Data ex-dywidendyKwotaWalutaStopa zwrotu
Gru 13, 2012$0,21USD≈0.84%

Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników

14
Średnie zaskoczenie 37.9%
Następny raport Paź 21, 2026
OkresRaportEPS ActualEPS SzacowanyNiespodzianka
30 czerwca 2026 Lip 21, 2026 $-0.19 $-0.06 -201.1%
31 marca 2026 $-0.48 $-0.10 -387.3%
31 grudnia 2025 $-0.01 $-0.10 90.5%
30 września 2025 $1.27 $-0.25 610.5%
30 czerwca 2025 $-0.05 $-0.11 52.6%
31 marca 2025 $-0.03 $-0.08 62.6%

Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne

15
Rachunek zysków i strat 13
Wskaźnik Trend 2025202420232022202120202019201820172016
Revenue $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Cost of Revenue $1.86B$1.95B$1.99B$1.98B$2.04B$1.96B$2.15B$2.35B$2.67B$3.01B
Operating Expenses $11.00B$12.09B$11.53B$11.39B$10.97B$10.66B$12.56B$13.95B$17.23B$19.30B
Operating Income $1.49B$542M$957M$821M$1.40B$1.13B$650M$208M$-1.88B$-860M
Interest Income $2M$3M$2M$2M$3M$3M$3M$7M$11M$14M
Pretax Income $724M$-283M$207M$349M$499M$422M$-430M$-715M$-2.83B$-1.72B
Income Tax $48M$79M$191M$170M$131M$-185M$160M$-11M$-449M$-104M
Net Income $509M$-516M$-133M$46M$230M$511M$-675M$-788M$-2.46B$-1.72B
EPS (Basic) $3.81$-3.90$-1.02$0.35$1.82$4.43$-5.93$-6.99$-22.00$-15.54
EPS (Diluted) $3.77$-3.90$-1.02$0.35$1.76$4.39$-5.93$-6.99$-22.00$-15.54
Shares (Basic) 133,564,227132,101,768130,445,677128,808,387126,754,852115,491,022113,739,046112,728,274111,769,821110,730,971
Shares (Diluted) 135,012,240132,101,768130,445,677130,060,319130,597,410116,544,561113,739,046112,728,274111,769,821110,730,971
EBITDA $1.49B$542M$957M$821M$1.40B$1.13B$1.26B$908M$-1.02B$240M
Bilans 26
Wskaźnik Trend 2025202420232022202120202019201820172016
Cash & Equivalents $260M$37M$38M$118M$507M$1.68B$216M$196M$563M$238M
Receivables $2.08B$2.29B$2.23B$2.04B$2.06B$1.93B$2.26B$2.35B$2.38B$3.18B
Other Current Assets $381M$358M$275M$235M$269M$338M$358M$400M$462M$568M
Current Assets $3.23B$3.30B$3.21B$3.08B$3.48B$4.51B$3.43B$3.55B$4.07B$4.67B
PP&E (Net) $4.50B$4.78B$5.21B$5.37B$5.55B$5.32B$5.61B$6.14B$7.05B$8.15B
PP&E (Gross) $8.91B$9.16B$9.51B$9.64B$9.76B$9.35B$9.65B$10.30B$11.50B$12.42B
Accum. Depreciation $4.41B$4.38B$4.30B$4.27B$4.20B$4.03B$4.04B$4.16B$4.45B$4.27B
Goodwill $3.32B$3.79B$3.96B$4.17B$4.22B$4.22B$4.33B$4.56B$4.72B$6.52B
Intangibles $7M$15M$20M$2M····$10M$14M
Other Non-current Assets $2.10B$2.17B$2.05B$2.01B$1.91B$1.90B$2.21B$1.54B$1.54B$2.59B
Total Assets $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Accounts Payable $842M$913M$912M$773M$830M$783M$811M$887M$967M$995M
Accrued Liabilities ······$1.13B$1.09B$1.13B$1.23B
Current Liabilities $2.21B$2.35B$2.14B$2.19B$2.36B$2.81B$2.28B$2.39B$2.36B$2.89B
Capital Leases $537M$535M$563M$605M$535M$524M$487M$84M$287M$302M
Deferred Tax $25M$231M$369M$354M$192M$29M$200M$26M$19M$411M
Other Non-current Liabilities $891M$828M$739M$644M$827M$1.60B$894M$1.01B$1.36B$1.57B
Total Liabilities $14.04B$15.37B$15.28B$15.40B$16.03B$17.06B$17.25B$16.82B$17.61B$19.66B
Long-term Debt $10.40B$11.45B$11.49B$11.63B$12.14B$12.22B$13.40B$13.60B$13.91B$15.24B
Total Debt $10.38B$11.43B$11.47B$11.61B$12.11B$12.09B$13.38B···
Common Stock $1M$1M$1M$1M$1M$1M$1M$1M$1M$1M
Retained Earnings $-3.57B$-4.08B$-3.56B$-3.43B$-3.48B$-3.71B$-4.22B$-3.54B$-2.76B$-299M
AOCI $-9M$-10M$-14M$-21M$-14M$-13M$-9M$-10M$-21M$-62M
Stockholders' Equity $-1.39B$-1.91B$-1.39B$-1.37B$-1.37B$-1.62B$-2.22B$-1.53B$-767M$1.61B
Liabilities + Equity $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Shares Outstanding 138,626,917138,919,641136,774,911134,703,717132,146,282129,612,117117,822,631116,248,376114,651,004113,876,580
Przepływy pieniężne 13
Wskaźnik Trend 2025202420232022202120202019201820172016
D&A $426M$486M$505M$534M$540M$558M$608M$700M$861M$1.10B
Stock-based Comp $11M$17M$22M$20M$25M$13M$10M$13M$24M$46M
Deferred Tax $-243M$-116M$35M$165M$171M$-187M$203M$-3M$-454M$-116M
Restructuring ····$3M·····
Other Non-cash ······$239M$352M$2.80B$1.83B
Operating Cash Flow $543M$480M$210M$300M$-131M$2.18B$385M$274M$773M$1.14B
CapEx $335M$360M$467M$415M$469M$440M$438M$527M$564M$744M
Investing Cash Flow $847M$-275M$-26M$-259M$-524M$177M$-2M$-245M$1.07B$630M
Net Debt Issued $-6.52B$-5.06B$-4.32B$-2.36B$-4.43B$-5.49B$-3.56B$-2.03B$-5.39B$-6.71B
Financing Cash Flow $-1.17B$-206M$-264M$-430M$-514M$-895M$-363M$-396M$-1.52B$-1.71B
Net Change in Cash $223M$-1M$-80M$-389M$-1.17B$1.46B$20M$-367M$325M$54M
Taxes Paid $249M$171M$91M$-6M$-4M$-2M$3M$19M$-4M$16M
Free Cash Flow $208M$120M$-257M$-115M$-600M$1.74B$-53M$-253M$209M$393M
Rentowność 7
Wskaźnik Trend 2025202420232022202120202019201820172016
Operating Margin 11.9%4.3%7.7%6.7%11.3%9.6%4.9%1.5%··
Net Margin 4.1%-4.1%-1.1%0.38%1.9%4.3%-5.1%-5.6%··
Pretax Margin 5.8%-2.2%1.7%2.9%4.0%3.6%-3.3%-5.1%··
EBITDA Margin 11.9%4.3%7.7%6.7%11.3%9.6%9.5%6.4%··
ROA 3.7%-3.6%-0.91%0.31%1.5%3.2%-4.3%-4.7%-12.5%-7.1%
ROE -30.8%31.2%9.6%-3.4%-15.3%-26.6%36.0%68.5%-580.0%-61.1%
ROIC 15.5%7.3%0.73%4.1%9.6%15.5%8.0%-13.3%206.0%-50.0%
Płynność i wypłacalność 4
Wskaźnik Trend 2025202420232022202120202019201820172016
Current Ratio 1.51.41.51.41.51.61.51.51.71.6
Quick Ratio 1.11.01.11.01.11.31.11.11.31.2
Debt / Equity -7.4-6.0-8.2-8.5-8.8-7.4-6.0···
LT Debt / Equity -7.4-6.0-8.2-8.5-8.8-7.4-6.0···
Efektywność 2
Wskaźnik Trend 2025202420232022202120202019201820172016
Asset Turnover 0.90.90.90.80.80.70.80.8··
Receivables Turnover 5.75.65.86.06.25.65.76.0··
Na akcję 5
Wskaźnik Trend 2025202420232022202120202019201820172016
Book Value / Share $-10.06$-13.78$-10.18$-10.15$-10.38$-12.54$-18.82$-13.20$-6.69$14.18
Revenue / Share $92.47$95.64$95.75$93.89$94.70$101.15$116.14$125.57··
Cash Flow / Share $4.02$3.63$1.61$2.31$-1.00$18.69$3.38$2.43$6.92$10.27
Cash / Share $1.88$0.27$0.28$0.88$3.84$12.93$1.83$1.69$4.91$2.09
EPS (TTM) $3.77$-3.90$-1.02$0.35$1.76$4.39$-5.93$-6.99$-22.00$-15.54
Stopy Wzrostu 9
Wskaźnik Trend 2025202420232022202120202019201820172016
Revenue YoY -1.2%1.1%2.3%-1.3%4.9%·····
Revenue CAGR 3Y 0.74%0.71%1.9%·······
Revenue CAGR 5Y 1.1%·········
EPS YoY ···-80.1%-59.9%·····
EPS CAGR 3Y 120.8%·········
EPS CAGR 5Y -3.0%·········
Net Income YoY ···-80.0%-55.0%·····
Net Income CAGR 3Y 122.8%·········
Net Income CAGR 5Y -0.08%·········
Wycena (TTM) 13
Wskaźnik Trend 2025202420232022202120202019201820172016
Revenue TTM $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Net Income TTM $509M$-516M$-133M$46M$230M$511M$-675M$-788M$-2.46B$-1.72B
Market Cap $433M$415M$428M$582M$1.76B$963M$342M$328M$488M$637M
Enterprise Value $10.55B$11.81B$11.86B$12.08B$13.36B$11.38B$13.51B···
P/E 0.8-0.8-3.112.37.61.7-0.5-0.4-0.2-0.4
P/S 0.00.00.00.00.10.10.00.00.00.0
P/B -0.3-0.2-0.3-0.4-1.3-0.6-0.2-0.2-0.60.4
P / Cash Flow 0.80.92.01.9-13.40.40.91.20.60.6
P / FCF 2.13.5-1.7-5.1-2.90.6-6.4-1.32.31.6
EV / EBITDA 7.121.812.414.79.510.110.7···
EV / FCF 50.798.4-46.1-105.0-22.36.5-254.9···
EV / Revenue 0.80.90.91.01.11.01.0···
Earnings Yield 120.8%-130.4%-32.6%8.1%13.2%59.1%-204.5%-247.9%-516.4%-278.0%

Najnowszy okres po lewej · wartości null pokazane jako ·

Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat

16
Wskaźnik 2025-12-312024-12-312023-12-312022-12-312021-12-31
Przychody $12.48B $12.63B $12.49B $12.21B $12.37B
Marża Operacyjna % 11.9% 4.3% 7.7% 6.7% 11.3%
Zysk netto $509M $-516M $-133M $46M $230M
Rozwodniony EPS $3.77 $-3.90 $-1.02 $0.35 $1.76

Właściciele instytucjonalni (13F) 196 emitentów · $415.1M łącznie · Na dzień 30 czerwca 2026

17

Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.

Posiadacze 196
Wartość posiadanych akcji $415.1M
Nowe pozycje 31
Zamknięte pozycje 24
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
Nowe pozycje Zamknięte pozycje Zwiększone Zmniejszony Zmiana liczby akcji netto
31 (+9 vs poprzedni kw.) 24 (+4 vs poprzedni kw.) 69 (+6 vs poprzedni kw.) 54 (-9 vs poprzedni kw.) +7.0M

Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.

Instytucja Wartość Akcje % z śledzonych 13F Typ
CastleKnight Management LP $44 704 517 13 384 586 10,77% Akcje
Apollo Management Holdings, L.P. $39 610 817 11 859 526 9,54% Akcje
BlackRock, Inc. $36 507 995 10 930 538 8,79% Akcje
VANGUARD GROUP INC $28 605 579 9 168 455 6,89% Akcje
Eversept Partners, LP $26 267 680 7 864 575 6,33% Akcje
NOMURA HOLDINGS INC $22 388 384 6 703 109 5,39% Akcje
VANGUARD CAPITAL MANAGEMENT LLC $17 668 370 5 289 931 4,26% Akcje
WHITEBOX ADVISORS LLC $12 467 362 3 732 743 3,00% Akcje
GEODE CAPITAL MANAGEMENT, LLC $10 582 352 3 167 702 2,55% Akcje
STATE STREET CORP $10 226 622 3 061 863 2,46% Akcje
VANGUARD PORTFOLIO MANAGEMENT LLC $10 082 117 3 018 598 2,43% Akcje
Saba Capital Management, L.P. $9 626 444 2 882 169 2,32% Akcje
Owl Creek Asset Management, L.P. $8 452 277 2 530 622 2,04% Akcje
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $8 176 380 2 448 018 1,97% Akcje
DIMENSIONAL FUND ADVISORS LP $7 854 253 2 351 460 1,89% Akcje
D. E. Shaw & Co., Inc. $7 829 388 2 344 128 1,89% Akcje
AQR CAPITAL MANAGEMENT LLC $7 651 362 2 290 827 1,84% Akcje
TWO SIGMA INVESTMENTS, LP $7 365 822 2 205 336 1,77% Akcje
Diameter Capital Partners LP $6 138 793 1 837 962 1,48% Akcje
BANK OF AMERICA CORP /DE/ $5 903 847 1 767 619 1,42% Akcje
GOLDMAN SACHS GROUP INC $5 868 073 1 756 908 1,41% Akcje
TWO SIGMA ADVISERS, LP $5 816 476 1 864 255 1,40% Akcje
CARRONADE CAPITAL MANAGEMENT, LP $5 230 000 1 565 847 1,26% Akcje
Allianz Asset Management GmbH $5 167 919 1 547 281 1,24% Akcje
MORGAN STANLEY $4 800 489 1 437 272 1,16% Akcje
NORTHERN TRUST CORP $4 681 414 1 401 621 1,13% Akcje
Silver Rock Financial LP $3 674 000 1 100 000 0,89% Akcje
CITADEL ADVISORS LLC $3 475 360 1 040 527 0,84% Akcje
Assenagon Asset Management S.A. $2 788 275 834 813 0,67% Akcje
VANGUARD FIDUCIARY TRUST CO $2 642 231 791 087 0,64% Akcje
Jefferies Financial Group Inc. $2 481 286 742 900 0,60% Akcje
Alta Fundamental Advisers LLC $2 161 411 647 129 0,52% Akcje
Bank of New York Mellon Corp $2 122 084 635 354 0,51% Akcje
MARSHALL WACE, LLP $1 906 575 570 831 0,46% Akcje
MILLENNIUM MANAGEMENT LLC $1 701 580 509 455 0,41% Akcje
ExodusPoint Capital Management, LP $1 664 603 498 384 0,40% Akcje
READYSTATE ASSET MANAGEMENT LP $1 657 729 496 326 0,40% Akcje
WOLVERINE ASSET MANAGEMENT LLC $1 339 674 401 100 0,32% Opcja kupna
Helix Partners Management LP $1 336 000 400 000 0,32% Akcje
Susquehanna Portfolio Strategies, LLC $1 280 940 383 515 0,31% Akcje
Voleon Capital Management LP $1 247 032 373 363 0,30% Akcje
Invesco Ltd. $1 076 599 322 335 0,26% Akcje
TUDOR INVESTMENT CORP ET AL $999 388 299 218 0,24% Akcje
Pathstone Holdings, LLC $895 621 268 150 0,22% Akcje
Prescott Group Capital Management, L.L.C. $863 076 258 406 0,21% Akcje
UBS Group AG $851 089 254 817 0,21% Akcje
MILLENNIUM MANAGEMENT LLC $835 000 250 000 0,20% Opcja sprzedaży
FEDERATED HERMES, INC. $812 599 243 293 0,20% Akcje
LPL Financial LLC $737 239 220 730 0,18% Akcje
IEQ CAPITAL, LLC $657 963 196 995 0,16% Akcje

Pokaż wszystkich 196 właścicieli instytucjonalnych →

Aktywiści i właściciele 5%+ 1 akcja

18

Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.

Zgłaszający Złożono Udział Status Cel Zgłoszenie
Tianqiao Chen, Shanda Media Limited, Shanda Global Investment Limited, Shanda Global Capital Limited, Shanda Asset Management Holdings Limited ×10 zgłoszenia 11 marca 2021 · Pierwotne zgłoszenie · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Insiderzy spółki 56 insiderów · 29 dyrektorzy generalni · 23 dyrektorzy

19
Insider Rola Ostatnia aktywność Posiadane akcje Kupna 12m Sprzedaże 12m Netto 12m
Kevin J Hammons CEO 1 marca 2026 A 895 545 0 0 $0
Tim Hingtgen CEO 1 marca 2025 A 1 388 781 0 0 $0
Jason K Johnson EVP & CFO 1 marca 2026 A 268 439 0 0 $0
Thomas J Aaron EVP and CFO 7 grudnia 2019 F 241 515 0 0 $0
Larry W Cash President and CFO 1 marca 2017 A 568 152 0 0 $0
Miguel S Benet President and CMO 1 marca 2025 D 47 635 0 0 $0
Austen D Mason Regional President 1 marca 2025 A 142 500 0 0 $0
Mark B Medley Regional President 1 marca 2025 A 128 637 0 0 $0
Chad A Campbell Regional President 1 marca 2025 A 136 815 0 0 $0
Charles J Cova Regional President 1 marca 2024 A 58 701 0 0 $0
Lynn T Simon President and CMO 1 marca 2024 A 482 657 0 0 $0
Beryl Ramsey Division President 1 marca 2019 A 62 969 0 0 $0
Patton Paul Smith Division President 1 marca 2019 F 119 017 0 0 $0
Iii John W Mcclellan Division President 1 marca 2017 A 41 242 0 0 $0
Robert O Horrar Division President 1 marca 2017 A 68 649 0 0 $0
Martin Bonick Division President 1 marca 2017 A 100 458 0 0 $0
Michael T Portacci Division President 1 marca 2017 A 110 156 0 0 $0
Thomas Daniel Miller Division President 1 marca 2016 A 112 107 0 0 $0
David Lewis Miller President and COO 1 marca 2016 A 440 840 0 0 $0
William S Hussey Division President 28 października 2015 M 121 568 0 0 $0
Martin Dewayne Smith Division President 3 czerwca 2015 M 94 111 0 0 $0
Gary D Newsome Division President - Group Ops 25 sierpnia 2008 M 118 286 0 0 $0
David V. Rice EVP-Clinical Operations & CMO 1 czerwca 2026 A 30 000 0 0 $0
Phillip A. Posey SVP & CAO 1 marca 2026 A 51 736 0 0 $0
Justin D Pitt Pres,Chief Legal&Admin Officer 1 marca 2026 A 287 750 0 0 $0
Kevin A Stockton EVP, Operations & Development 1 marca 2026 A 208 290 0 0 $0
Rachel A Seifert Executive VP and Secretary 1 marca 2017 F 243 065 0 0 $0
Mark T Buford SVP/Chief Accounting Officer 25 lutego 2012 F 78 379 0 0 $0
Martin G Schweinhart Senior Vice President 1 marca 2006 A 40 354 0 0 $0
William Norris Jennings Dyrektor 25 sierpnia 2026 S 38 468 0 1 $-118 400
Ranga K Krishnan Dyrektor 30 czerwca 2026 M 170 023 0 0 $0
Fawn D Lopez Dyrektor 1 marca 2026 A · 0 0 $0
Ronald L Burgess JR Dyrektor 1 marca 2026 A · 0 0 $0
Susan W Brooks Dyrektor 1 marca 2026 A 108 695 0 0 $0
Hubert James Williams Dyrektor 1 marca 2026 A 211 863 0 0 $0
Joseph Arthur Hastings Dyrektor 1 marca 2026 A 0 0 0 $0
Elizabeth T Hirsch Dyrektor 1 marca 2026 A 162 059 0 0 $0
James S. Ely III Dyrektor 1 marca 2026 A 412 876 0 0 $0
John A Fry Dyrektor 1 marca 2026 A 268 966 0 0 $0
John A Clerico Dyrektor 1 marca 2026 A 368 763 0 0 $0
Michael Dinkins Dyrektor 1 marca 2026 A 225 882 0 0 $0
Wayne T Smith Dyrektor 1 marca 2026 A 5 217 579 0 0 $0
Julia B North Dyrektor 1 marca 2021 A 162 056 0 0 $0
Mitchell H Watson JR Dyrektor 16 maja 2017 M 22 594 0 0 $0
Harvey Klein MD Dyrektor 15 marca 2010 M 10 383 0 0 $0
Dale F Frey Dyrektor 31 marca 2008 A 20 000 0 0 $0
Thomas H Lister Dyrektor 21 września 2004 S 0 0 0 $0
Thodore Forstmann Dyrektor 21 września 2004 S 0 0 0 $0
Sandra Horbach Dyrektor 21 września 2004 S 0 0 0 $0
Robert J Dole Dyrektor 6 maja 2004 S 0 0 0 $0
FLC XXIX PARTNERSHIP LP Posiadacz 10% 21 września 2004 S 0 0 0 $0
FLC XXX PARTNERSHIP LP Posiadacz 10% 21 września 2004 S 0 0 0 $0
Winston Hutchins Posiadacz 10% 21 września 2004 S 0 0 0 $0
FORSTMANN LITTLE & CO SUB DEBT & EQU MGMT BUYOUT PART VI LP Posiadacz 10% 21 września 2004 S 0 0 0 $0
FORSTMANN LITTLE & CO EQUITY PARTNERSHIP V L P Posiadacz 10% 21 września 2004 S 0 0 0 $0
Benjamin C Fordham · 1 marca 2021 A 254 608 0 0 $0

Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S

Posiadanie ETF-ów Posiadane przez 25 funduszy ETF

20

Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.

Fundusz Waga Jednostki Na dzień Źródło
BSJR · Invesco Exchange-Traded Self-Indexe… 2,68% 23 297 000 1 października 2026 Dziennie
EBIT · Harbor ETF Trust 0,45% 19 210 NS 31 lipca 2026 N-PORT
IWC · iShares Trust 0,09% 443 690 SH 11 września 2026 Dziennie
IHF · iShares Trust 0,05% 223 947 SH 11 września 2026 Dziennie
VTWV · VANGUARD SCOTTSDALE FUNDS 0,03% 113 109 SH 19 sierpnia 2026 Dziennie
NEAR · iShares U.S. ETF Trust 0,03% 1 340 000 SH 11 września 2026 Dziennie
PRFZ · Invesco Exchange-Traded Fund Trust 0,02% 226 491 SH 1 października 2026 Dziennie
IWM · iShares Trust 0,01% 3 425 206 SH 11 września 2026 Dziennie
RSSL · Global X Funds 0,01% 62 038 NS 31 lipca 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,01% 746 733 SH 19 sierpnia 2026 Dziennie
VHT · VANGUARD WORLD FUND 0,01% 349 881 SH 19 sierpnia 2026 Dziennie
DFAS · Dimensional ETF Trust 0,01% 289 348 NS 31 lipca 2026 N-PORT
DFAC · Dimensional ETF Trust 0,00% 202 789 NS 31 lipca 2026 N-PORT
DFAU · Dimensional ETF Trust 0,00% 33 838 NS 31 lipca 2026 N-PORT
ITOT · iShares Trust 0,00% 203 848 SH 11 września 2026 Dziennie
IWV · iShares Trust 0,00% 42 177 SH 3 września 2026 Dziennie
DCOR · Dimensional ETF Trust 0,00% 6 184 NS 31 lipca 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 31 135 NS 31 lipca 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,00% 1 347 195 SH 19 sierpnia 2026 Dziennie
VTI · VANGUARD INDEX FUNDS 0,00% 3 813 888 SH 19 sierpnia 2026 Dziennie
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 9 817 SH 19 sierpnia 2026 Dziennie
DFSU · Dimensional ETF Trust 0,00% 24 NS 31 lipca 2026 N-PORT
VGHY · VANGUARD FIXED INCOME SECURITIES FU… · · 15 lipca 2026 Dziennie
VPLS · VANGUARD MALVERN FUNDS · · 15 lipca 2026 Dziennie
IWN · iShares Trust · 1 223 127 SH 11 września 2026 Dziennie

CYH Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu

21
ocena · 16 analityków TRZYMAJ
Średni cel $3.12 +14,9%
1 6,2% Mocne kupno
1 6,2% Kup
6 37,5% Trzymaj
7 43,8% Sprzedaj
1 6,2% Mocna sprzedaż

12-miesięczny cel cenowy

8 analityków · 2026-10-01

Średnia cel $3.16 +16,0%

Teraz Aktualna cena $2.72
Niski$2.00 Średnia$3.16 Wysoki$4.00

Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora

22

Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.

Ticker Kapitalizacja Rynkowa P/E Przychody r/r Marża Netto ROE Marża brutto
CYH $433M 0.8 -1.2% 4.1% -30.8% ·
SGRY $2.00B -25.3 6.2% -2.4% -4.5% ·
NUTX $1.17B 15.7 82.4% 8.1% 30.6% 50.8%
ARDT $1.26B 9.2 6.0% 2.1% 11.2% ·
USPH · 55.0 16.3% 5.1% 8.2% 19.2%
STLN · · · · · ·
JYNT $123M 45.9 5.2% 5.3% 16.3% ·
HCA $104.86B 16.5 7.1% 9.0% -159.1% ·

Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie

23

Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów

26

Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.

Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.

Źródło: SEC 10-Q złożone Lip 23, 2026